METFORMIN AND ELAFIBRANOR SALT HAVING DUAL ACTIVITY FOR THE TREATMENT OF OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATO-HEPATITIS (NASH) AND HYPERTRIGLYCERIDEMIA

摘要

The present invention relates to drugs derived from elafibranor. It relates more particularly to a composition comprising at least one active ingredient characterized in that at least one active ingredient comprises a metformin salt of elafibranor. The present invention also relates to an elafibranor derivative having dual activity for the treatment of obesity associated with nonalcoholic steatohepatitis (NASH) and hypertriglyceridemia.